Tafasitamab (Anti-CD19)
Product Specifications
CAS Number
1422527-84-1
Synonyms
XmAb5574; MOR00208; Tafasitamab-cxix
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2039417-01 0.1 mL
APC-Linked Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
Sign In for Pricing
View Details MBS2039417-02 0.2 mL
APC-Linked Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
Sign In for Pricing
View Details MBS2039417-03 0.5 mL
APC-Linked Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
Sign In for Pricing
View Details MBS2039417-04 1 mL
APC-Linked Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
Sign In for Pricing
View Details MBS2039417-05 5 mL
APC-Linked Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
Sign In for Pricing
View Details MBS2039417-06 5x 5 mL
APC-Linked Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
Sign In for Pricing
View Details